Amanta Healthcare Limited (NSE:AMANTA)
India · Delayed Price · Currency is INR 104.24
+3.62 (3.60%)
At close: Jan 21, 2026
Amanta Healthcare Revenue
Amanta Healthcare had revenue of 708.87M INR in the quarter ending September 30, 2025, with 4.10% growth. This brings the company's revenue in the last twelve months to 2.76B. In the fiscal year ending March 31, 2025, Amanta Healthcare had annual revenue of 2.75B, down -2.01%.
Revenue (ttm)
2.76B
Revenue Growth
-2.01%
P/S Ratio
1.24
Revenue / Employee
5.29M
Employees
522
Market Cap
3.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.75B | -56.32M | -2.01% |
| Mar 31, 2024 | 2.80B | 212.11M | 8.19% |
| Mar 31, 2023 | 2.59B | 336.88M | 14.94% |
| Mar 31, 2022 | 2.25B | 541.47M | 31.61% |
| Mar 31, 2021 | 1.71B | -130.73M | -7.09% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sudarshan Pharma Industries | 5.92B |
| ZIM Laboratories | 3.66B |
| Albert David | 3.16B |
| Everest Organics | 1.89B |
| Medico Remedies | 1.72B |
| Medicamen Biotech | 1.70B |
| Jenburkt Pharmaceuticals | 1.59B |
| Gennex Laboratories | 1.49B |